The MacBook Pro is back in the spotlight. This time, the upgrade is not small. It is big, bold, and built for serious users. In March 2026, Apple Inc. introduced the new MacBook Pro powered by the all new M5 Pro and M5 Max chips.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
The Indian stock market faced heavy selling pressure today as the Sensex dropped sharply by more than 600 points, while the Nifty slipped below the 24,800 mark. The fall was driven by weak global cues, profit booking in heavyweight stocks, and investor caution ahead of key economic data. Continue Reading on Meyka This article is…
On February 12, 2026, the Gold Price dipped sharply after a stronger-than-expected U.S. jobs report weakened expectations for near-term interest rate cuts by the Federal Reserve. Investors closely monitor gold because it does not pay interest, so its value is especially sensitive to changes in interest rate expectations, the strength of the U.S. dollar, and…
Infosys’ Q2 showed strong numbers. Yet the stock slipped after the report. In this article, we explain why that happened. We look at the headline numbers, management commentary, broker views, and what investors should watch next. The focus keyword for this article is Infosys Q2. Continue Reading on Meyka This article is available in full…
Canada’s postal system is at the centre of a national standoff. On Thursday, the Canadian Union of Postal Workers (CUPW) announced an immediate nationwide strike in response to a government push for major operational reforms. The walkout shuts down many Canada Post operations and threatens longer-term changes to how Canadians get mail. Continue Reading on…
HDFC Bank stock price went up by 1% on July 15, 2025. This jump came just before a key board meeting scheduled for July 20. In this meeting, the board will consider two major decisions: a bonus share issue and a special dividend for shareholders. Continue Reading on Meyka This article is available in full…
The Anthem Biosciences IPO Allotment status has finally been released, and investors are eagerly checking whether they’ve got a piece of the much-anticipated public issue. With a strong response from all investor categories and a solid grey market premium (GMP), this IPO has become one of the most talked-about offerings this year. Continue Reading on…